SMS Pharma.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE812G01025
  • NSEID: SMSPHARMA
  • BSEID: 532815
INR
317.00
-5.45 (-1.69%)
BSENSE

Dec 05

BSE+NSE Vol: 3.78 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Net Sales
438.48
361.20
301.98
223.82
337.70
243.02
235.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
438.48
361.20
301.98
223.82
337.70
243.02
235.03
Raw Material Cost
253.22
266.01
195.32
148.86
247.06
144.14
164.10
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-2.42
-62.35
-23.00
3.09
-66.11
10.96
-17.33
Employee Cost
37.44
34.81
27.20
25.69
24.02
18.03
19.27
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
45.46
40.19
32.06
26.07
30.19
18.23
17.77
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
17.05
17.56
16.40
7.36
11.31
6.13
5.59
Total Expenditure (Excl Depreciation)
350.75
296.22
247.98
211.07
246.47
197.49
189.40
Operating Profit (PBDIT) excl Other Income
87.73
64.98
54.00
12.75
91.23
45.53
45.63
Other Income
2.03
2.67
1.32
1.41
2.64
1.31
1.23
Operating Profit (PBDIT)
89.76
67.65
55.32
14.16
93.87
46.84
46.86
Interest
11.58
9.27
11.89
10.09
9.78
5.67
6.41
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
78.18
58.38
43.43
4.07
84.09
41.17
40.45
Depreciation
19.77
17.00
15.59
16.03
16.08
11.11
10.69
Profit Before Tax
58.41
41.37
27.84
-11.95
68.01
30.06
29.76
Tax
14.57
11.14
6.99
-2.49
19.80
9.63
10.73
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
43.84
30.24
20.86
-9.46
48.21
20.43
19.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
43.84
30.24
20.86
-9.46
48.21
20.43
19.03
Share in Profit of Associates
1.96
0.34
0.21
-5.32
-1.62
-2.43
-1.38
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
45.80
30.58
21.07
-14.78
46.59
18.00
17.65
Equity Capital
9.37
8.47
8.47
8.47
8.47
8.47
8.47
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
4.89
3.61
2.49
-1.74
5.5
2.13
2.08
Diluted Earnings per share
5.13
3.61
2.49
-1.75
5.5
2.13
2.09
Operating Profit Margin (Excl OI)
20.01%
17.99%
17.88%
5.7%
27.02%
18.74%
19.41%
Gross Profit Margin
17.83%
16.16%
14.38%
1.82%
24.9%
16.94%
17.21%
PAT Margin
10.0%
8.37%
6.91%
-4.23%
14.28%
8.41%
8.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 21.40% vs 19.61% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is 49.77% vs 45.14% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 35.01% vs 20.33% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 24.92% vs -22.04% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of SMS Pharma. With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
438.48
698.90
-260.42
-37.26%
Other Operating Income
0.00
0.00
0.00
Total Operating income
438.48
698.90
-260.42
-37.26%
Raw Material Cost
253.22
400.70
-147.48
-36.81%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-2.42
-87.60
85.18
97.24%
Employee Cost
37.44
132.50
-95.06
-71.74%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
45.46
0.00
45.46
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
17.05
221.00
-203.95
-92.29%
Total Expenditure (Excl Depreciation)
350.75
666.60
-315.85
-47.38%
Operating Profit (PBDIT) excl Other Income
87.73
32.30
55.43
171.61%
Other Income
2.03
2.90
-0.87
-30.00%
Operating Profit (PBDIT)
89.76
35.20
54.56
155.00%
Interest
11.58
32.00
-20.42
-63.81%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
78.18
3.20
74.98
2,343.12%
Depreciation
19.77
80.60
-60.83
-75.47%
Profit Before Tax
58.41
-77.40
135.81
175.47%
Tax
14.57
-20.10
34.67
172.49%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
43.84
-57.30
101.14
176.51%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
43.84
-57.30
101.14
176.51%
Share in Profit of Associates
1.96
0.00
1.96
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
45.80
-57.30
103.10
179.93%
Equity Capital
9.37
24.70
-15.33
-62.06%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
4.89
-4.64
9.53
205.39%
Diluted Earnings per share
5.13
-4.65
9.78
210.32%
Operating Profit Margin (Excl OI)
20.01%
4.70%
0.00
15.31%
Gross Profit Margin
17.83%
0.47%
0.00
17.36%
PAT Margin
10.00%
-8.33%
0.00
18.33%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 438.48 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 21.40% vs 19.61% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 45.80 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 49.77% vs 45.14% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 87.73 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 35.01% vs 20.33% in Sep 2024

Half Yearly - Interest
Interest 11.58 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 24.92% vs -22.04% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.01%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024